Innovative technologies co-developed in an interdisciplinary partnership targeting better diagnostic and treatment of widespread complex diseases:
Researchers, physicians, engineers, patients, students, equipment vendors, and public health system stakeholders all working together to devise the medical technologies of tomorrow...
Inauguration of the TransMedTech Institute
Polytechnique Montréal and numerous partners will collaborate to devise the medical technologies of tomorrow.
Read the article
The mission of the TransMedTech Institute is to develop next-generation medical technologies for the diagnosis, prognosis, treatment, and rehabilitation of three major groups of diseases: cancer, cardiovascular illnesses and musculoskeletal disorders.
Co-creation of solutions
The cornerstone of the TransMedTech Institute is its transdisciplinary, intersectoral, open-innovation ecosystem. Better known as a living lab, this is a new-design approach to health research and innovation.
The living-lab model collectively involves researchers, engineers, students, physicians, caregivers, industries, policy-makers, governments and patients in the rapid generation of innovative technology solutions and approaches to healthcare delivery.
- Accelerated processes of development, clinical validation, and transfer to the healthcare system.
- Better matching of technology solutions to the needs of healthcare users.
- Promote collaborative transdisciplinary and intersectoral research as well as innovation and creativity, via the living-lab approach.
- Accelerate transfers to industry as well as integration of novel treatment modes and new technologies into the healthcare system.
- Target significant social and economic impacts.
- Establish international networks and partnerships.
- Attract and train qualified next-generation medical-technology professionals with an accent on diversity.
- Develop a medical-technology showcase and centre of attraction.
Strategic research areas
|MUSCULOSKELETAL DISORDERS||CARDIOVASCULAR DISEASES||CANCER|
|BIOSENSORS AND MEDICAL MICRODEVICES||●||●|
|PROGNOSTIC TESTS FOR PROGRESSIVE PATHOLOGIES||●||●|
|MINIMALLY INVASIVE TREATMENT DEVICES||●||●|
|IMAGING, LASER THERAPIES, BIOPHOTONIC PROBES||●||●||●|
|NANOROBOTICS AND THERANOSTICS TECHNOLOGY||●||●||●|
|MULTIMODAL INTERVENTIONAL IMAGING||●||●||●|
Toward improved quality of life for people living with disabilities
|Biosensors and medical microdevices|
Toward new approaches to diagnosing neurological and cardiovascular diseases as well as cancer tumours
|Prognostic tests for progressive pathologies|
Toward improved quality of life for patients with musculoskeletal disorders
|Minimally invasive treatment devices|
Toward novel treatments for joint degeneration, pediatric musculoskeletal disorders and cardiovascular diseases
|Imaging, laser therapies, biophotonic probes|
Toward improved prospects of recovery via more precise and effective treatment methods
|Nanorobotics and theranostics technology|
Toward new avenues for treatment of cancer tumours
|Multimodal interventional imaging|
Toward more effective personalized treatments for cardiovascular and neuromusculoskeletal conditions
|Carl-Éric Aubin P.Eng., Ph.D.
Chief Executive and Scientific Officer
514 340-4711 ext. 2836
View expertise background
Assistant to Chief Executive and Scientific Officer
(514) 345-4931 ext. 7011 (CHU Sainte-Justine)
(514) 340-4711 ext. 3739 (Polytechniuque)
|Development, Partnerships and Operations|
|Karine Genest, M.Sc., MBA
Manager, Administration and Finance
(514) 340-4711, ext. 3732
Manager, Communications and Marketing
(514) 340-4711, ext. 3757
|Living Lab Unit|
|Marie-Pierre Faure, Ph. D.
Assistant Director – Living Lab Unit
|Charles Vachon, M.Sc., MBA
Senior Advisor, Regulatory Affairs
(514) 345-4931, ext. 6461
David McLauchlan, M.Sc., LL.B.
|Catherine Marchand, Ph.D.
Senior Advisor, Project Management
(514) 345-4931, ext. 4320
(514) 345-4931, ext. 4327
Research, Innovation and International Affairs
|Augustin Brais, Eng.
Directeur adjoint, Direction de la recherche, de l'innovation et des affaires internationales (DRIAI)
|Neïla Kaou, Ph. D.
Conseillère au développement et partenariats, Direction de la recherche, de l'innovation et des affaires internationales (DRIAI)
(514) 340-4711 ext. 2154
Attracting, training and retaining top talents
Working at the heart of the open-innovation ecosystem at the TransMedTech Institute, students acquire exceptional scientific and entrepreneurial skills, including:
- proficiency in basic, applied and clinical research methodologies;
- expertise in technological innovation; and
- understanding of challenges, concepts and cultures specific to various disciplines and areas.
Boasting some 60 researchers including leading players in their respective fields, health professionals, major names in the medical technology industry, and essential health-sector policy-makers, the TransMedTech clearly has what it takes to attract the best talents.
Tronsdisciplinory and intersectorol partnerships are at the heart of the TronsMedTech lnstitute scientific strotegy.
- Canada First Research Excellence Fund
- Ministère de l'Économie, de la Science et de l'lnnovation, Québec
- Fonds de recherche du Québec
- Office of the Chief Scientist, Québec
- Univalor Fondation du CHU Sainte-Justine Fondation de Polytechnique
- Jewish General Hospital Foundation
- Fondation Mélia
- Université Aix-Marseille
- Boston Brace
- Zimmer Biomet
- Technoparc Montréal
- Centre of Excellence on Partnership with Patients and the Public
- National Scoliosis Foundation
- Scoliosis Research Society
- Coalition priorité cancer au Québec
- MIMO Study Group
and several other organizations in the process of joining
Professor & Chief Executive and Scientific Director, Montreal TransMedTech Institute
(514) 340-4711 poste 2836